mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors
Background Perturbation of the mechanistic target of rapamycin (mTOR) pathway can instruct effector versus memory cell fate of tumor antigen-specific T cells in preclinical models. In this study, we sought to understand the impact of rapamycin (sirolimus), an mTOR inhibitor, on reprogramming vaccine...
Saved in:
| Main Authors: | Li Yan, Nina Bhardwaj, Tibor Keler, Kunle Odunsi, Song Liu, Junko Matsuzaki, Takemasa Tsuji, Mark Long, Thinle Chodon, Emese Zsiros, Protul Shrikant, Jianming Wang, Alan Hutson, Stephanie Blank, Amit Lugade, Richard Koya, Spencer R Rosario, Henry G Withers, Shashikant B Lele |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/3/e010408.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer
by: Wenjun He, et al.
Published: (2021-10-01) -
WHSC1/NSD2 regulates immune infiltration in prostate cancer
by: Kunle Odunsi, et al.
Published: (2021-02-01) -
Phyllodes Tumor of the Breast Metastasizing to the Vulva
by: Olusegun Kayode Ajenifuja, et al.
Published: (2015-01-01) -
Mending the divide: integrating opioid analgesia and immunotherapy for optimal cancer care
by: Emese Zsiros, et al.
Published: (2025-05-01) -
Święta Marcela – wzór odnowy duchowej w czasie kryzysu cywilizacyjnego
by: Konrad Keler
Published: (2013-06-01)